Rare Diseases: Considerations for the Development of Drugs and Biological Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 26, 2023
April 11, 2024
de40ca53-dec2-46b7-8321-a251e09d47bb
Related Documents
Benefit-Risk Assessment for New Drug and Biological Products
Guidance DocumentOctober 17, 2023Center for Drug Evaluation and Research
Development of Anti-Infective Drug Products for the Pediatric Population : Guidance for Industry
Guidance DocumentDecember 9, 2021Center for Drug Evaluation and Research
Qualification Process for Drug Development Tools Guidance for Industry and FDA Staff
Guidance DocumentNovember 24, 2020Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.